178 related articles for article (PubMed ID: 10682309)
21. [Metachromatic leukodystrophy (MLD) and Multiple sulphatase deficiency (MSD)].
Eto Y; Hasegawa Y; Tsuda T
Nihon Rinsho; 1995 Dec; 53(12):2994-3003. PubMed ID: 8577048
[TBL] [Abstract][Full Text] [Related]
22. Additional biochemical findings in a patient and fetal sibling with a genetic defect in the sphingolipid activator protein (SAP) precursor, prosaposin. Evidence for a deficiency in SAP-1 and for a normal lysosomal neuraminidase.
Paton BC; Schmid B; Kustermann-Kuhn B; Poulos A; Harzer K
Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):481-8. PubMed ID: 1637339
[TBL] [Abstract][Full Text] [Related]
23. Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease.
Schnabel D; Schröder M; Sandhoff K
FEBS Lett; 1991 Jun; 284(1):57-9. PubMed ID: 2060627
[TBL] [Abstract][Full Text] [Related]
24. Degradation of membrane-bound ganglioside GM1. Stimulation by bis(monoacylglycero)phosphate and the activator proteins SAP-B and GM2-AP.
Wilkening G; Linke T; Uhlhorn-Dierks G; Sandhoff K
J Biol Chem; 2000 Nov; 275(46):35814-9. PubMed ID: 10942779
[TBL] [Abstract][Full Text] [Related]
25. Mutational analysis in a patient with a variant form of Gaucher disease caused by SAP-2 deficiency.
Rafi MA; de Gala G; Zhang XL; Wenger DA
Somat Cell Mol Genet; 1993 Jan; 19(1):1-7. PubMed ID: 8460394
[TBL] [Abstract][Full Text] [Related]
26. Sphingolipid activator protein B deficiency: report of 9 Saudi patients and review of the literature.
Al-Hassnan ZN; Al Dhalaan H; Patay Z; Faqeih E; Al-Owain M; Al-Duraihem A; Faiyaz-Ul-Haque M
J Child Neurol; 2009 Dec; 24(12):1513-9. PubMed ID: 19955343
[TBL] [Abstract][Full Text] [Related]
27. A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse.
Matsuda J; Vanier MT; Saito Y; Tohyama J; Suzuki K; Suzuki K
Hum Mol Genet; 2001 May; 10(11):1191-9. PubMed ID: 11371512
[TBL] [Abstract][Full Text] [Related]
28. Late Infantile Metachromatic Leukodystrophy Due to Novel Pathogenic Variants in the PSAP Gene.
Kolnikova M; Jungova P; Skopkova M; Foltan T; Gasperikova D; Mattosova S; Chandoga J
J Mol Neurosci; 2019 Apr; 67(4):559-563. PubMed ID: 30632081
[TBL] [Abstract][Full Text] [Related]
29. Nucleotide sequence of cloned cDNA for human sphingolipid activator protein 1 precursor.
Dewji NN; Wenger DA; O'Brien JS
Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8652-6. PubMed ID: 2825202
[TBL] [Abstract][Full Text] [Related]
30. Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids.
Fujita N; Suzuki K; Vanier MT; Popko B; Maeda N; Klein A; Henseler M; Sandhoff K; Nakayasu H; Suzuki K
Hum Mol Genet; 1996 Jun; 5(6):711-25. PubMed ID: 8776585
[TBL] [Abstract][Full Text] [Related]
31. Prosaposin deficiency: further characterization of the sphingolipid activator protein-deficient sibs. Multiple glycolipid elevations (including lactosylceramidosis), partial enzyme deficiencies and ultrastructure of the skin in this generalized sphingolipid storage disease.
Bradová V; Smíd F; Ulrich-Bott B; Roggendorf W; Paton BC; Harzer K
Hum Genet; 1993 Sep; 92(2):143-52. PubMed ID: 8370580
[TBL] [Abstract][Full Text] [Related]
32. Processing of sphingolipid activator proteins and the topology of lysosomal digestion.
Sandhoff K; Kolter T
Acta Biochim Pol; 1998; 45(2):373-84. PubMed ID: 9821868
[TBL] [Abstract][Full Text] [Related]
33. Metachromatic leukodystrophy without arylsulfatase A deficiency: a new case of saposin-B deficiency.
Deconinck N; Messaaoui A; Ziereisen F; Kadhim H; Sznajer Y; Pelc K; Nassogne MC; Vanier MT; Dan B
Eur J Paediatr Neurol; 2008 Jan; 12(1):46-50. PubMed ID: 17616409
[TBL] [Abstract][Full Text] [Related]
34. Sphingolipid activator protein D (sap-D) stimulates the lysosomal degradation of ceramide in vivo.
Klein A; Henseler M; Klein C; Suzuki K; Harzer K; Sandhoff K
Biochem Biophys Res Commun; 1994 May; 200(3):1440-8. PubMed ID: 8185598
[TBL] [Abstract][Full Text] [Related]
35. Studies on a sphingolipid activator protein (SAP-2) in fibroblasts from patients with lysosomal storage diseases, including Niemann-Pick disease Type C.
Fujibayashi S; Wenger DA
Clin Chim Acta; 1985 Mar; 146(2-3):147-56. PubMed ID: 3921288
[TBL] [Abstract][Full Text] [Related]
36. Sulfatide activator protein. Alternative splicing that generates three mRNAs and a newly found mutation responsible for a clinical disease.
Holtschmidt H; Sandhoff K; Kwon HY; Harzer K; Nakano T; Suzuki K
J Biol Chem; 1991 Apr; 266(12):7556-60. PubMed ID: 2019586
[TBL] [Abstract][Full Text] [Related]
37. Saposin B-Deficient Metachromatic Leukodystrophy Mimicking Acute Flaccid Paralysis.
Madaan P; Jauhari P; Chakrabarty B; Kumar A; Gulati S
Neuropediatrics; 2019 Oct; 50(5):318-321. PubMed ID: 31319425
[TBL] [Abstract][Full Text] [Related]
38. Human sphingolipid activator protein-1 and sphingolipid activator protein-2 are encoded by the same gene.
Reiner O; Dagan O; Horowitz M
J Mol Neurosci; 1989; 1(4):225-33. PubMed ID: 2484333
[TBL] [Abstract][Full Text] [Related]
39. Analysis of recombinant human saposin A expressed by Pichia pastoris.
Yamada M; Inui K; Hamada D; Nakahira K; Yanagihara K; Sakai N; Nishigaki T; Ozono K; Yanagihara I
Biochem Biophys Res Commun; 2004 May; 318(2):588-93. PubMed ID: 15120640
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a recombinant molecule covalently indistinguishable from human cerebroside-sulfate activator protein (CSAct or Saposin B).
Whitelegge JP; Ahn V; Norris AJ; Sung H; Waring A; Stevens RL; Fluharty CB; Prive G; Faull KF; Fluharty AL
Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):799-807. PubMed ID: 14528917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
